key: cord-0917943-re61zd8l
authors: Liauw, Jessica; Gundy, Serena; Rochwerg, Bram; Hutcheon, Jennifer A.
title: Antenatal Corticosteroids and COVID-19: balancing benefits and harms
date: 2020-08-25
journal: Am J Obstet Gynecol
DOI: 10.1016/j.ajog.2020.08.062
sha: ce5392c750dbb2459902aeb4a97cf46ab74b3291
doc_id: 917943
cord_uid: re61zd8l

nan

corticosteroids for fetal lung maturity in pregnant women with COVID-19. We believe this 27 recommendation warrants further discussion. First, we would like to highlight that the impact of 28 corticosteroid treatment in non-pregnant patients with COVID-19 is currently unclear, 29 precluding conclusions about likely maternal harm in the context of COVID-19. Second, we 30 argue that in these unique circumstances, decision-making about the use of antenatal 31 corticosteroids should keep in mind that the absolute benefits of antenatal corticosteroids for 32 fetal lung maturity changes on a week-by-week basis during pregnancy. recognize that the absolute benefits of antenatal corticosteroids differ on a week-by-week basis 52 as gestational age advances and the baseline risks of neonatal morbidity decrease. In births <34 53 weeks' gestation, the absolute risk reduction of Respiratory Distress Syndrome associated with 54 antenatal corticosteroids is 128 fewer cases per 1000, from a baseline risk of 310 per 1000. 6 In 55 contrast, we recently estimated that the absolute risk reduction of neonatal ventilation >6 hours 56 associated with antenatal corticosteroids in those born at 34 weeks' gestation is 24 fewer cases 57 per 1000 (95% CI: 14 to 35), from a US population baseline risk of 64 per 1000, and at 36 58 weeks' it is 7 fewer cases per 1000 (95% CI: 4 to 9), from a baseline risk of 17 per 1000. 7 59 60 As obstetrical care providers strive to provide the best care in these unique circumstances, 61 considering week-by-week absolute benefits of antenatal corticosteroids allows us to best weigh 62 potential harms and benefits of this treatment alongside our critical care colleagues. These 63 conversations will be crucial to minimize maternal harm while reducing the burden of neonatal 64 respiratory morbidity in a time when ventilation resources are of paramount importance. 65 66 J o u r n a l P r e -p r o o f

COVID-19) and pregnancy: What obstetricians need to know